New horizons in lung cancer management through ATR/CHK1 pathway modulation
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New horizons in lung cancer management through ATR/CHK1 pathway modulation
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume 15, Issue 19, Pages 1807-1818
Publisher
Future Science Ltd
Online
2023-10-25
DOI
10.4155/fmc-2023-0164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phytochemical Profile and In Vitro Bioactivities of Plant-Based By-Products in View of a Potential Reuse and Valorization
- (2023) Ilaria Chiocchio et al. Plants-Basel
- Recent advances in DDR (DNA damage response) inhibitors for cancer therapy
- (2022) Binbin Cheng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic Targeting of DNA Damage Response in Cancer
- (2022) Wonyoung Choi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cell cycle involvement in cancer therapy; WEE1 kinase, a potential target as therapeutic strategy
- (2022) Sajjad Vakili-Samiani et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Ciclopirox Olamine Exerts Tumor-Suppressor Effects via Topoisomerase II Alpha in Lung Adenocarcinoma
- (2022) Jie Yin et al. Frontiers in Oncology
- ACTL6A deficiency induces apoptosis through impairing DNA replication and inhibiting the ATR-Chk1 signaling in glioblastoma cells
- (2022) Xiaosong Hu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status
- (2022) Margarita Pustovalova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cell cycle checkpoints and beyond: Exploiting the ATR/CHK1/WEE1 pathway for the treatment of PARP inhibitor–resistant cancer
- (2022) Nitasha Gupta et al. PHARMACOLOGICAL RESEARCH
- Lung Cancer
- (2022) Aundrea L. Oliver SURGICAL CLINICS OF NORTH AMERICA
- Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer
- (2022) Erika Durinikova et al. CLINICAL CANCER RESEARCH
- Multi-Level Control of the ATM/ATR-CHK1 Axis by the Transcription Factor E4F1 in Triple-Negative Breast Cancer
- (2022) Kalil Batnini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Influence of PARP, ATR, CHK1 Inhibitors on Premature Mitotic Entry and Genomic Instability in High-Grade Serous BRCAMUT and BRCAWT Ovarian Cancer Cells
- (2022) Patrycja Gralewska et al. Cells
- ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus
- (2022) Theodora Manolakou et al. Science Advances
- Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer
- (2022) Siyao Deng et al. Cancers
- Anti-cancer immune responses to DNA damage response inhibitors: Molecular mechanisms and progress toward clinical translation
- (2022) Lindsey Carlsen et al. Frontiers in Oncology
- ATR Inhibition in Advanced Urothelial Carcinoma
- (2022) Ryan C. Leibrandt et al. Clinical Genitourinary Cancer
- DNA Damage Response Signaling Is Crucial for Effective Chikungunya Virus Replication
- (2022) Sanchari Chatterjee et al. JOURNAL OF VIROLOGY
- Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeres
- (2022) Natalia Maciejewska et al. Cell Death & Disease
- p53 triggers mitochondrial apoptosis following DNA damage-dependent replication stress by the hepatotoxin methyleugenol
- (2022) Max J. Carlsson et al. Cell Death & Disease
- Polysaccharide-Based Nanomedicines Targeting Lung Cancer
- (2022) Asif Ahmad Bhat et al. Pharmaceutics
- LncRNA linc00312 suppresses radiotherapy resistance by targeting DNA-PKcs and impairing DNA damage repair in nasopharyngeal carcinoma
- (2021) Zhen Guo et al. Cell Death & Disease
- Targeting Non-Oncogene Addiction for Cancer Therapy
- (2021) Hae Ryung Chang et al. Biomolecules
- Chk1 Inhibition Induces a DNA Damage Bystander Effect in Cocultured Tumour Cells
- (2021) Teresa Brooks et al. DNA REPAIR
- Clinical Candidates Targeting the ATR–CHK1–WEE1 Axis in Cancer
- (2021) Lukas Gorecki et al. Cancers
- DNA damage response inhibitors: An avenue for TNBC treatment
- (2021) Juan Jin et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Methylation of NRN1 is a novel synthetic lethal marker of PI3K‐Akt‐mTOR and ATR inhibitors in esophageal cancer
- (2021) Wushuang Du et al. CANCER SCIENCE
- Inhibition of checkpoint kinase 1 potentiates anticancer activity of gemcitabine in bladder cancer cells
- (2021) Makoto Isono et al. Scientific Reports
- Critical role of SMG7 in activation of the ATR-CHK1 axis in response to genotoxic stress
- (2021) Kathleen Ho et al. Scientific Reports
- Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells
- (2021) Andrea Ghelli Luserna Di Rorà et al. CELL BIOLOGY AND TOXICOLOGY
- Lung cancer
- (2021) Alesha A Thai et al. LANCET
- Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy
- (2021) M. Janaki Ramaiah et al. LIFE SCIENCES
- Tumor-associated exosomes promote lung cancer metastasis through multiple mechanisms
- (2021) Chunyang Jiang et al. Molecular Cancer
- CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer
- (2021) Sipei Nie et al. Journal of Ovarian Research
- Molecular Pathology of Lung Cancer
- (2021) Sinchita Roy-Chowdhuri Surgical Pathology Clinics
- PARP inhibitor resistance in ovarian cancer: Underlying mechanisms and therapeutic approaches targeting the ATR/CHK1 pathway
- (2021) Łukasz Biegała et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- DNA Damage Repair Inhibitors—Combination Therapies
- (2021) Gabriella Smith et al. CANCER JOURNAL
- JAK Inhibition Prevents DNA Damage and Apoptosis in Testicular Ischemia-Reperfusion Injury via Modulation of the ATM/ATR/Chk Pathway
- (2021) Farah Khashab et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Centipeda minima extract sensitizes lung cancer cells to DNA-crosslinking agents via targeting Fanconi anemia pathway
- (2021) Xiang-Zhen Fan et al. PHYTOMEDICINE
- APE2 Is a General Regulator of the ATR-Chk1 DNA Damage Response Pathway to Maintain Genome Integrity in Pancreatic Cancer Cells
- (2021) Md Akram Hossain et al. Frontiers in Cell and Developmental Biology
- Vitamin-Containing Antioxidant Formulation Reduces Carcinogen-Induced DNA Damage through ATR/Chk1 Signaling in Bronchial Epithelial Cells In Vitro
- (2021) J.P. Jose Merlin et al. Biomedicines
- A Genome-Wide Pooled shRNA Screen Identifies PPP2R2A as a Predictive Biomarker for the Response to ATR and CHK1 Inhibitors
- (2020) Zhaojun Qiu et al. CANCER RESEARCH
- Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future
- (2020) Iris Z. Uras et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NRF2 preserves genomic integrity by facilitating ATR activation and G2 cell cycle arrest
- (2020) Xiaohui Sun et al. NUCLEIC ACIDS RESEARCH
- Effects of Sclareol Against Small Cell Lung Carcinoma and the Related Mechanism: In Vitro and In Vivo Studies
- (2020) HSIANG LAI CHEN et al. ANTICANCER RESEARCH
- Apoptosis (programmed cell death) and its signals - A review
- (2020) E. Obeng BRAZILIAN JOURNAL OF BIOLOGY
- Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives
- (2020) Matthijs Oudkerk et al. Nature Reviews Clinical Oncology
- Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives
- (2020) Evgeny N. Imyanitov et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Function and molecular mechanisms of APE2 in genome and epigenome integrity
- (2020) Yunfeng Lin et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand
- (2019) Lin Mei et al. Journal of Hematology & Oncology
- Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine
- (2019) Zay Yar Oo et al. Molecular Oncology
- Phytochemical Naphtho[1,2-b] furan-4,5-dione Induced Topoisomerase II-mediated DNA Damage Response in Human Non-small-Cell Lung Cancer
- (2018) Ching-Ming Chien et al. PHYTOMEDICINE
- ATR/CHK1 inhibitors and cancer therapy
- (2018) Zhaojun Qiu et al. RADIOTHERAPY AND ONCOLOGY
- Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer
- (2018) Yuehong Wang et al. CANCER LETTERS
- Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer
- (2017) Guangbo Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer
- (2017) Fabian Doerr et al. Scientific Reports
- PP2A as a master regulator of the cell cycle
- (2016) Nathan Wlodarchak et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Axl Receptor Axis: A New Therapeutic Target in Lung Cancer
- (2016) Pavel A. Levin et al. Journal of Thoracic Oncology
- ARRB1 enhances the chemosensitivity of lung cancer through the mediation of DNA damage response
- (2016) Hongchang Shen et al. ONCOLOGY REPORTS
- Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
- (2015) Edgar Pérez-Herrero et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- PNAS-4, an Early DNA Damage Response Gene, Induces S Phase Arrest and Apoptosis by Activating Checkpoint Kinases in Lung Cancer Cells
- (2015) Zhu Yuan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970
- (2015) Amy B. Hall et al. Oncotarget
- NSC746364, a G-Quadruplex-Stabilizing Agent, Suppresses Cell Growth of A549 Human Lung Cancer Cells Through Activation of the ATR/Chk1-Dependent Pathway
- (2014) Yun-Lung Chung et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Role of AKT signaling in DNA repair and clinical response to cancer therapy
- (2014) Q. Liu et al. NEURO-ONCOLOGY
- Apoptosis and Molecular Targeting Therapy in Cancer
- (2014) Mohamed Hassan et al. Biomed Research International
- Role of Nrf2 in Oxidative Stress and Toxicity
- (2013) Qiang Ma Annual Review of Pharmacology and Toxicology
- Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer
- (2013) Parthasarathy Seshacharyulu et al. CANCER LETTERS
- Roles of Chk1 in cell biology and cancer therapy
- (2013) Youwei Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Celecoxib Enhances the Radiosensitizing Effect of 7-Hydroxystaurosporine (UCN-01) in Human Lung Cancer Cell Lines
- (2012) Young-Mee Kim et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Depletion of HDAC6 Enhances Cisplatin-Induced DNA Damage and Apoptosis in Non-Small Cell Lung Cancer Cells
- (2012) Lei Wang et al. PLoS One
- Inhibition of checkpoint kinase 1 sensitizes lung cancer brain metastases to radiotherapy
- (2011) Heekyoung Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started